Events

Upcoming

Wednesday 5 October

MPP, UNITAID and INAPI host side event, Enhancing Patent and Licensing Transparency for Medicines, during 56th WIPO General Assemblies, 13.00-15.00

Past events

The MPP’s summer newsletter is out!

The MPP publishes its July 2016 newsletter featuring an update on its last six months of progress.

The New York Times – New strategies to fight AIDS

Letter to the editor from MPP’s Executive Director

Voluntary Patent Pooling: Encouraging Rapid Scale-Up of Medicines for Resource-Limited Countries

Read a blog post by Greg Perry, MPP’s Executive Director

Medicines Patent Pool statement, 69th World Health Assembly

Agenda item 15.1 – WHO Global Health Sector Strategies for HIV and Viral Hepatitis
MPP representative: Greg Perry
Full statement

Generics Bulletin: “Medicines Patent Pool has potential for wider scope”

Read the article

MPP Submission to the UN High-Level Panel on Access to Medicines

Read the MPP submission.

MPP Newsletter – January 2016

One licence for a HCV medicine, two new disease areas, four new board members, $120 million in savings: check out MPP’s January newsletter for an update on top initiatives in Q3/Q4 2015.

Global Innovative Financing for the Next Decade

Greg Perry and Philippe Douste-Blazy in Global Health and Diplomacy Magazine

New agreements for TAF signed with Lupin and Micro Labs

View our sub-licensees section

Ensuring new medicines reach those in most need

Read MPP’s Executive Director, Greg Perry and Head of Policy, Esteban Burrone’s comment published in the  The Lancet HIV